...
首页> 外文期刊>Cardiovascular engineering and technology >Fabrication and Testing of Electrospun Polyurethane Blended with Chitosan Nanoparticles for Vascular Graft Applications
【24h】

Fabrication and Testing of Electrospun Polyurethane Blended with Chitosan Nanoparticles for Vascular Graft Applications

机译:用壳聚糖纳米粒子混合电动梭纳米粒子的制备和测试血管移植件

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, a small vascular graft based on polyurethane (PU) blended with chitosan (Ch) nanoparticles was fabricated using electrospinning technique. Initially, the chitosan nanoparticles were synthesized using ionic gelation method. UV-Vis spectrophotometer confirmed the presence of synthesized Ch nanoparticles by exhibiting absorption peak at 288 nm and the Fourier-transform infrared spectroscopy (FTIR) analysis confirmed the existence of the chitosan. Further, the synthesized Ch nanoparticles showed size diameter in the range of 134 +/- 58 nm as measured using ImageJ. In the electrospun PU/chitosan graft, the fiber diameter and pore size diameter was found to be reduced compared to the pure PU owing to incorporation of chitosan into PU matrix. The FTIR spectrum revealed the presence of chitosan in the prepared nanocomposite membrane by the formation of the hydrogen bond and peak shift of CH and NH stretching. Moreover, the contact angle measurements revealed that the prepared graft showed decreased contact angle indicating hydrophilic nature compared to the pristine PU. The cytocompatibility studies revealed the non-toxic behavior of the fabricated graft. Hence, the prepared graft exhibiting significant physiochemical and non-toxic properties may be a plausible candidate for cardiovascular graft applications.
机译:本研究采用静电纺丝技术制备了一种基于聚氨酯(PU)和壳聚糖(Ch)纳米颗粒共混的小型血管移植物。最初,采用离子凝胶法合成了壳聚糖纳米颗粒。通过在288 nm处显示吸收峰,紫外-可见分光光度计证实了合成的Ch纳米颗粒的存在,傅立叶变换红外光谱(FTIR)分析证实了壳聚糖的存在。此外,使用ImageJ测量,合成的Ch纳米颗粒的粒径在134+/-58 nm范围内。在静电纺PU/壳聚糖接枝物中,由于壳聚糖的加入,与纯PU相比,纤维直径和孔径减小。FTIR光谱显示,通过氢键的形成以及CH和NH拉伸的峰移,壳聚糖存在于所制备的纳米复合膜中。此外,接触角测量显示,与原始PU相比,制备的接枝物显示出降低的接触角,表明其具有亲水性。细胞相容性研究揭示了所制备的移植物的无毒性。因此,具有显著理化和无毒特性的制备的移植物可能是心血管移植物应用的合理候选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号